Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × COVID-19 × acalabrutinib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma, Mantle-Cell 8 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Hairy Cell 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1 Glioblastoma 1 DLBCL 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Anemia, Hemolytic, Autoimmune 1

Interventions

tocilizumab 1 sotrovimab 1 proxalutamide 1 bemcentinib 1 Therapeutics 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Janus Kinase Inhibitors 1 Influenza Vaccines 1 Hydroxychloroquine 1 HuMax-IL8 1 Gelsolin 1 Diagnostic Tests, Routine 1 Decision Support Techniques 1 COVID-19 Vaccines 1 Blood Specimen Collection 1 BNT162 Vaccine 1 2019-nCoV Vaccine mRNA-1273 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡